Mesenchymal stem cells, osteogenic lineage and bone tissue engineering: A review

Journal of Animal and Veterinary Advances

Volumn 10, Issue 17, 2011, Pages 2317-2330

  Kaveh, Kamran ^a   Ibrahim, Rashid ^a   Abu Bakar, Md Zuki ^a   Ibrahim, Tengku Azmi ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Bone tissue engineering; Malaysia; Mesenchymal stem cell; Osteoblasts; Regenerative medicine; Scaffold

Indexed keywords

EID: 84870925320     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: 10.3923/javaa.2011.2317.2330     Document Type: Review

References (122)

1. Al-Khaldi, A, H Al-Sabti, J. Galipeau and K. Lachapelle, 2003. Therapeutic angiogenesis using autologous bone marrow stromal cells: Improved blood flow in a chronic limb ischemia model. Ann. Thorac. Surg., 75: 204-209.
2. Alberts, B., A Johuson, J. Lewis, M. Raff, K. Roberts and P. Walter, 2002. Molecular Biology of the Cell. 2nd EOO., Garland Science, New York.
3. Aronow, MA, i.c Gerstenfeld, TA Owen, M.S. Tassinari, G.S. Stein and J.B. Lian, 1990. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J. Cell. Physiol., 143: 213-221.
4. Atrnani, H., e. Audrain, L. Mercier, D. Chappard and M.F. Basle, 2002. Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells. J. Cell. Biochem., 85: 640-650.
5. Ballas, o.s., S.P. Zielske and S.L. Gerson, 2002. Adult bone marrow stem cells for cell and gene therapies: Implications for greater use. 1 Cell. Biochem., 85: 20-28.
6. Banfi, A, G. Bianchi, R Notaro, L. Luzzatto, R Cancedda and R Quarto, 2002. Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng., 8: 901-910.
7. Barling, P.M., J.H. Bennett, JT Triffitt and M.E. Owen, 1989. The adenylate cyclase response to parathyroid hormone in cultured rabbit marrow fibroblastic cells. Bone Mineral, 7: 23-30.
8. Barry, F.P., RE. Boynton, S. Haynesworth, J.M. Murphy and J. Zaia, 1999. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CDI05). Biochem. Biophys. Res. Commun., 265: 134-139.
9. Barry, F., R Boynton, M. Murphy and J. Zaia, 2001. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem. Biophys. Res. Commun., 289: 519-524.
10. Baylink, D.l, 1983. Glucocorticoid-induced osteoporosis. N. Engl. J. Med., 309: 306-308.
11. Beck Jr., G.R, B. Zerler and E. Moran, 2000. Phosphate is a specific signal for induction of osteopontin gene expreSSIOn. Proc. Nat!. Acad. Sci. USA., 97: 8352-8357.
12. Bellows, c.o., JN.M. Heersche and J.E. Aubin, 1990. Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence of dexamethasone. Dev. BioI., 140: 132-138.
13. Bemyahu, n, Y. Kletter, D. Zipori and S. Wientroub, 1989. Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo. J. Cell. Physiol., 140: 1-7.
14. Bronckers, AL., S. Gay, RD. Finkehuan and W.T. Butler, 1987. Developmental appearance of Gla proteins (osteocalcin) and alkaline phosphatase in tooth germs and bones of the rat. Bone Miner., 2: 361-373.
15. Bruder, S.P., M.e. Horowitz, J.D. Mosca and S.B. Haynesworth, 1997 a. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone, 21. 225-235.
16. Bruder, S.P., N. Jaiswal and S.E. Hayuesworth, 1997b. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell. Biochem., 64: 278-294.
17. Bruder, S.P., N.S. Ricalton, RE. Boyuton, TT Connolly, N. Jaiswal, J. ZaiaandF.P. Barry, 1998. Mesenchymal stem cell surface antigen SB-I0 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. 1 Bone Miner. Res., 13: 655-663.
18. Cano, E. and L.e. Mahadevan, 1995. Parallel signal processing among mammalian 1.1APKs. Trends Biochem. Sci., 20: 117-122.
19. Caplan, A and S. Bruder, 1997. Stem Cell. In: Principles of Tissue Engineering, Langer, R and W. Chick (Iids.). RG. Landes, New York, pp: 603-618.
20. Caplan, AI., 1991. Mesenchymal stem cells. J. Orthopaedic Res., 9: 641-650.
21. Caplan, AI., 1993. Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells. United States Patent 5197985. http://www.freepatentsonline.com/5197985.html.
22. Caplan, AI., G.T. Syftestad and P. Osdoby, 1983. The development of embryonic bone and cartilage in tissue culture. Clin. Orthop. Relat Res., 174: 243-263.
23. Castro-Malaspina, R., RE. Gay, G. Resnick, N. Kapoor and P. Meyers et aI., 1980. Characterization of human bone marrow fibroblast colony-fonning cells (CFU-F) and their progeny. Blood, 56: 289-301.
24. Charbord, P., AM. Gown, A Keating and I.W. Singer, 1985. CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures. Blood, 66: 1138-1142.
25. Cheng, S.L., J.W. Yang, L. Rifas, S.F. Zhang and L.v. Avioli, 1994. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology, 134: 277-286.
26. Chung, OH. EE Golub, E Forbes, T. Tokuoka and I.M. Shapiro, 1992. Mechanism of action of betaglycerophosphate on bone cell mineralization. Calcif. Tissue Int, 51: 305-311.
27. Ccnget, PA and J.J. Minguell, 1999. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J. Cell Physiol., 181:67-73.
28. Darimont, G.L., R Cloots, E. Heinen, L. Seidel and R Legrand, 2002. In vivo behaviour of hydroxyapatite coatings on titanium implants: A quantitative study in the rabbit. Biomaterials, 23: 2569-2575.
29. Deng, W., M Obrocka, I. Fischer and D.J. Prockop, 2001. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic A1'v1P. Biochem. Biophys. Res. Commun., 282: 148-152.
30. Dennis, J.E., J.P. Carbillet, AI. Caplan and P. Charbord, 2002. The STRO-l+ marrow cell population is multipotential. Cells Tissues Organs., 170: 73-82.
31. Dexter, TM., T.D. AllenandL.G. Lajtha, 1997. Conditions controlling the proliferation of haemopoietic stem cells in vitro. I. CelL PhysioL, 91: 335-344.
32. D'lppolito1, G., P.e. Schiller, e. Ricordi, B.A Roos1 and G.A. Howard, 1999. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J. Bone Miner. Res., 14: 1115-1122.
33. Falla, N., V. Vlasselaer, J. Bierkens, B. Borremans, G. Schoeters and U. van Gorp, 1993. Characterization of a 5-fluorouracil-emiched osteoprogenitor population of the murine bone marrow. Blood, 82: 3580-3591.
34. Ferrari, G., G.e.D. Angelis, M. Coletta, E. Paolucci, A. Stomaiuolo, G. Cossu and F. Mavilio, 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science, 279: 1528-1530.
35. Fortuna, R, He. Anderson, RP. Carty and S.W. Sajdera, 1980. Enzymatic characterization of the matrix vesicle alkaline phosphatase isolated from bovine fetal epiphyseal cartilage. Calcif Tissue Int., 30: 217-225.
36. Fouillard, L., M. Bensidhoum, D. Bories, H. Bonte and M. Lopez el 01., 2003. Engraftrnent of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia, 17: 474-476.
37. Friedenstein, AJ., I.I. Piatetzky-Shapiro and K.V. Petrakova, 1966. Osteogenesis in transplants of bone marrow cells. I. EmbryoL Exp. MorphoL, 16: 381-390.
38. Friedenstein, AJ., RK. Chailakhjan And K.S. Lalykina, 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Proliferat., 3: 393-403.
39. Friedenstein, AJ., RK. Chailakhyan and UV. Gerasimov, 1987. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers. Cell Proliferat., 20: 263-272.
40. Fuchs, S., R Baffour, YF. Zhou, M. Shou and A. Pierre et aI., 2001. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J. Am. ColI. Cardiol., 37: 1726-1732.
41. Fujita, T., N. Izurno, R Fukuyama, T. Meguro, H Nakamuta, T. Kolino and M. Koida, 2001. Phosphate provides an extracellular signal that drives nuclear export ofRunx2/Cbfal in bone cells. Biochem. Biophys. Res. Commun., 280: 348-352.
42. Galotto, M., G. Berisso, L. Delfino, M. Podesta and L. Ottaggio el 01., 1999. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp. Hematol., 27: 1460-1466.
43. Gilbert, M., CM. Giachelli and P.S. Stayton, 2003. Biomimetic peptides that engage specific integrindependent signaling pathways and bind to calcium phosphate surfaces. J. Biomed. Mater. Res., 67A 69-77.
44. Gojo, S., N. Gojo, Y Takeda, T. Mori and H Abe el 01., 2003. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp. Cell Res., 288: 51-59.
45. Graves, S.E., CA Smoothy, J.N. Beresford and M.J.O. Francis, 1991. L-ascorbic acid 2-phosphate promotes proliferation, differentiation and matrix production of human bone-derived cells. J. Bone Joint Surg., 73: 126-130.
46. Gronthos, S. and P.J. Simmons, 1996. Ihe biology and application of human bone marrow stromal cell precursors. J. Hematother., 5: 15-23.
47. Gronthos, S., x.c Zannettino, S.I. Hay, S. Shi, S.B. Graves, A. Kortesidis and P.I. Simmons, 2003. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci., 116: 1827-1835.
48. Gronthos, S., S.E. Graves, S. Ohtaand P.I. Simmons, 1994. Ihe SIRO-l+ fraction of adult human bone marrow contains the osteogenic precursors. Blood, 84: 4164-4173.
49. Groot, G.G., JX. Danes, J. Blok, A Hoogendijk and P.Y. Hauschka, 1986. Light and electron microscopic demonstration of osteocalcin antigenicity III embryonic and adult rat bone. Bone, 7: 379-385.
50. Hanai, J., L.F. Chen, I. Kanno, N. Ohtani-Fujita and W.Y. Kim et al., 1999. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin gennline Calpha promoter. J. BioI. Chem., 274: 31577-31582.
51. Hannjorg, K., 2009. Bone tissue engmeenng. http://www.btec.cffiu.edultutorial/bone_tissue_engineering/bone_tissue_engineering.htm Hans, RS., 2007. Ihe Potential of Stem Cells: An Inventory. In: Hwnanbiotechnology as Social Challenge, Nikolaus, K, S. Dagmar and L.S. Stefan (Eds.). Ashgate Publishing Ltd., UK., pp: 28.
52. Hans, RS., 2007. Ihe Potential of Stem Cells: An Inventory. In: Hwnanbiotechnology as Social Challenge, Nikolaus, K, S. Dagmar and L.S. Stefan (Eds.). Ashgate Publishing Ltd., UK., pp: 28.
53. Haynesworth, S., M. Barber and A Caplan, 1992a. Cell surface antigens on human marrow derived mesenchymal stem cells are detected by monoclonal antibodies. Bone, 13: 69-80.
54. Haynesworth, S.E., J Goshima, V.M. Goldberg and AI. Caplan, 1992b. Characterization of cells with osteogenic potential from human marrow. Bone, 13: 81-88.
55. Hitomi, K., Y. Torii and N. Tsukagoshi, 1992. Increase in the activity of alkaline phosphatase by L-ascorbic acid 2-phosphate in a human osteoblast cell line, HuO-3NI. J. Nutr. Sci. Vitaminol., 38: 535-544.
56. Horwitz, EM., DJ. Prockop, LA Fitzpatrick, W.W.K. Koo and P.L. Gordon et al, 1999. Iransplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med., 5: 309-313.
57. Jackson, KA, S.M. Majka, H. Wang, J. Pocius and c.J. Hartley et al., 2001. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest., 107: 1395-1402.
58. Jaiswal, N., S.E. Haynesworth, AI. Caplan and S.P. Bruder, 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell Biochem., 64: 295-312.
59. Jaiswal, R.K., N. Jaiswal, S.P. Bruder, G. Mbalaviele, D.R Marshak andM.F. Pittenger, 2000. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. BioI. Chern., 275: 9645-9652.
60. Kamalia, N,. CA McCulloch, He. Ienebaum and H. Limeback, 1992. Dexamethasone recruitment of self-renewing osteoprogenitor cells in chick bone marrow stromal cell cultures. Blood, 79: 320-326.
61. Kaveh, K., R Ibrahim and M. Keshavarz, 2008. Characteristics and potentials of mesenchymal stem cell as a multipotent stem cell. IJSD, 8: 17-22.
62. Kaveh, K, M.z. A Bakar, R Ibrahim and I.A Ibrahim, 2009. Repair of compact bone critical sized defect with natural originated scaffold in rabbit. J. Anim. Vet. Adv., 8: 1616-1623.
63. Kaveh, K, R Ibrahim, M.ZA Bakar and I.A Ibrahim, 201 O. Bone grafting and bone graft substitutes. J. Anim. Vet. Adv., 9: 1055-1067.
64. Kneser, U, DJ. Schaefer, B. Polykandriotis and RE. Horch, 2006. Tissue engineering of bone: The reconstructive surgeon's point of view. J. Cell. Mol. Med., 10: 7-19.
65. Kobayashi, I., K Hamano, I.S. Li, I. Katoh, S. Kobayashi, M. Matsuzaki and K. Esato, 2000. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J. Surg. Res., 89: 189-195.
66. Koc, ON., S.L. Gerson, B.W. Cooper, S.M. Dyhouse, S.B. Haynesworth, AI. Caplan and HM. Lazarus, 2000a. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol., 18: 307-316.
67. Koc, O.N., J. Day, M. Nieder, S.L. Gerson, HM. Lazarus and W. Krivit, 2000b. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPSIH). Bone Marrow Iransplant., 30: 215-222.
68. Kopen, o.c., D.J. Prockop and D.G. Phinney, 1999. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. USA, 96: 10711-10716.
69. Koshihara, Y, M Kawamura, H Oda and S. Higaki, 1987. In vitro calcification in human osteoblastic cell line derived from periosteum. Biochem. Biophys. Res. Commun., 145: 651-657.
70. Kuznetsov, S.A., P.H. Krebsbach, K. Satomura, J. Kerr, M. Riminucci, D. Benayahu and P.G. Robey, 1997. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res., 12: 1335-1347.
71. Langer, R. and J.P. Vacanti, 1993. Tissue engineering. Science, 260: 920-926.
72. Lazarus, H.M., S.B. Haynesworth, S.L. Gerson, N.S. Rosenthal and AI. Caplan, 1995. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic lise. Bone Marrow Transplant., 16: 557-564.
73. Leboy, P.S., I.N. Beresford, C. Devlin and M.E. Owen, 1991. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J. Cell. Physiol., 146: 370-378.
74. Lee, K.S., HI. Kim, Q.L. Li, XZ. Chi and C. Ueta el 01., 2000. RWlX2 is a common target of transforming growth factor betal and bone morphogenetic protein 2, and cooperation between RWlX2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell BioI., 20: 8783-8792.
75. Lee, K.S., S.H. Hong and S.c. Bae, 2002. Both the Smad and p38 MAPK pathways playa crucial role in Runx2 expression following induction by transforming growth factor- and bone morphogenetic protein. Oncogene, 21: 7156-7163.
76. Lian, J.E. and G.S. Stein, 1992. Concepts of osteoblast growth and differentiation: Basis for modulation of bone cell development and tissue formation. Crit. Rev. Oral BioI. Med., 3: 269-305.
77. Lisa, A.F., 2005. Stem cells: Classifications, controversies and clinical applications. Vet. Surg., 34: 415-423. Liu, F., J.E. Aubin and L. Malaval, 2002. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: Differential regulation by dexamethasone andLIF. Bone, 31: 212-219.
78. Liu, F., J.E. Aubin and L. Malaval, 2002. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: Differential regulation by dexamethasone andLIF. Bone, 31: 212-219.
79. LoCascio, v., E. Bonucci, B. Imbimbo, P. Ballanti and S. Adami et aI., 1990. Bone loss in response to longterm glucocorticoid therapy. Bone Miner., 8: 39-51.
80. Majumdar, MK., MA Thiede, J.D. Mosca, M. Moorman and S.L. Gerson, 1998. Phenotypic and functional companson of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. CelL PhysioL, 176: 57-66.
81. Malaval, L., D. Modrowski, AK. Gupta and I.E. Aubin, 1994. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. I. CelL PhysioL, 158: 555-572. Maniatopoulos, c., I. Sodek and AH Melcher, 1988. Bone formation in vitro by stromal cells obtained from bone marrow of yOllllg adult rats. Cell Tissue Res., 254: 317-330.
82. Maniatopoulos, c., I. Sodek and AH Melcher, 1988. Bone formation in vitro by stromal cells obtained from bone marrow of yOllllg adult rats. Cell Tissue Res., 254: 317-330.
83. Mark, M.P., C.W. Prince, S. Gay, RL. Austin, M. Bhown, RD. Finkelinan and W.T. Butler, 1987a. A comparative immunocytochemical study on the subcellular distributions of 44 kDa bone phosphoprotein and bone a-carboxyglutamic acid (Gla)-containing protein ill osteoblasts. J. Bone Miner. Res., 2: 337-346.
84. Mark, M.P., C.W. Prince, T. Oosawa, S. Gay, AL. Bronckers and W.T. Butler, 1987b. Immunohistochemical demonstration of a 44-KD phosphoprotein III developing rat bones. J. Histochem. Cytochem., 35: 707-715.
85. Manony, S., F. Bassilana, K. Seuwen and H. Keller, 2003. Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone, 33: 426-433.
86. Meijer, GJ., I.D. de Bruijn, R Koole and C.A van Blitterswijk, 2007. Cell-based bone tissue engineering. PLoS Med., 4: e9-e9.
87. Migliaccio, A., M. di Domenico, G. Castoria, A. de Falco, P. Bontempo, E. Nola and F. Auricchio, 1996. Tyrosine kinase/p2lras/1.1AP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO. J., 15: 1292-1300.
88. Minguell, J.J., A Erices and P. Conget, 2001: Mesenchymal stem cells. Exp. Biol. Med., 226: 507-520.
89. Mitalipov, S. and D. Wolf, 2009. Totipotency, pluripotency and nuclear reprogramming. Adv. Biochem. Eng. Bioteclinol., 114: 185-199.
90. Miura, Y and S.W. O'Driscoll, 1998. Culturing periosteum in vitro: The influence of different sizes of explants. Cell Transplant., 7: 453-457.
91. Miyachi, Y, 2000. Pathophysiology and diagnosis of Cushing's syndrome. Biomed. Phannacother., 54: 113s-117s.
92. Muraglia, A, R Cancedda and R Quarto, 2000. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell. Sci., 113: 1161-1166.
93. Murphy, I.M., K. Dixon, S. Beck, D. Fabian, A Feldman and F. Barry, 2002. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum, 46: 704-713.
94. Nuttelman, C.R, 2005. Osteogenic poly (ethylenglycol)based hydrogel for three dimentional human mesenchymal stem cell culture and bone regeneration. Doctoral Thesis, University of Colorado, United States of America.
95. Oreffo, RO., S. Bord and J.T. Triffitt, 1998. Skeletal progenitor cells and ageing human populations. Clin. Sci.,94: 549-555.
96. Owen, M., 1988. Marrow stromal stem cells. J. Cell. Sci., 10: 63-76.
97. Owen, TA, M. Aronow, V. Shalhoub, L.M. Barone and L. Wilrning et al., 1990. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell Physiol., 143: 420-430.
98. Peter, ST, C.R Liang, DJ. Kim, M.S. Widmer and A G. Mikos, 1998. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, a-glycerolphosphate and L-ascorbic acid. J. Cell. Biochem., 71: 55-62.
99. Pittenger, M.F., AM Mackay, S.c. Beck, RK Jaiswal and R Douglas et al., 1999. Multilineage potential of adult human mesenchymal stem cells. Science, 284: 143-147.
100. Pockwinse, S.M, L.G. Wihning, D.M. Conlon, G.S. Stein and J.B. Lian, 1992. Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures. J. Cell. Biochem., 49: 310-323.
101. Polak, J.M. and AE. Bishop, 2006. Stem cells and tissue engineering: Past, present and future. Ann. New York Acad. Sci., 1068: 352-366.
102. Porter, RM., W.R Huckle andAS. Goldstein, 2003. Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells. J. Cell. Biochem., 90: 13-22.
103. Quarto, R., M. Mastrogiacomo, R. Cancedda, S.M. Kutepov and V. Mukhachev et al, 2001. Repair of large bone defects with the use of autologous bone marrow stromal cells. New England J. Med., 344: 385-386.
104. Robey, P.G. and J.D. Termine, 1985. Human bone cells in vitro. Calcif Tissue. Int., 37: 453-460.
105. Robison, R and K.M. Soarnes, 1924. The possible significance of hexophosphoric esters in ossification. Biochem. J., 17: 186-293.
106. Sarnbrook, P., J. Birmingham, S. Kempler, P. Kelly and S. Eberl et al., 1990. Corticosteroid effects on proximal femur bone loss. J. Bone Miner. Res., 5: 1211-1216.
107. Sanchez-Ramos, J., S. Song, F. Cardozo-Pelaez, C. Hazzi and T. Stedeford et al, 2000. Adult bone marrow stromal cells differentiate into neural cells in vitro. ExpNeurol., 164: 247-256.
108. Sanchez-Ramos, J.R., 2002. Neural cells derived from adult bone marrow and umbilical cord blood. J. Neurosci. Res.,69: 880-893.
109. Short, B., N. Brouard, T. Occhiodoro-Scott, A Rarnakrishnan andPJ. Simmons, 2003. Mesenchymal stem cells. Arch. Med. Res., 34: 565-571.
110. Simmons, DJ., P. Seitz, L. Kidder, G.L. Klein and M. Waeltz et aI., 1991. Partial characterization of rat marrow stromal cells. Calcif. Tissue Int., 48: 326-334.
111. Simmons, PT and B. Torok-Storb, 1991. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood, 78: 55-62.
112. Strobel, E.S., RE. Gay and P.L. Greenberg, 1986. Characterization of the in vitro stromal microenvironment ofhuman bone marrow. Int. J. Cell. Cloning, 4: 341-356.
113. Tarnir, A, T. Petrocelli, K. Stetler, W. Chu and J. Howard et al., 2000. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1cyelin- dependent kinase complexes: A role for p27 in erythroid differentiation coupled G1 arrest. Cell. Growth Differ., 11. 269-277.
114. Tenenbaum, HC., H Limeback, CA McCulloch, H. Marnujee, B. Sukhu and M. Torontali, 1992. Osteogenic phase-specific co-regulation of collagen synthesis and mineralization by betaglycerophosphate in chick periosteal cultures. Bone, 13: 129-138.
115. Thies, RS., M. Bauduy, B.A Ashton, L. Kwtzberg, J.M. Womey and V. Rosen, 1992. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology, 130: 1318-1324.
116. Turksen, K. and J.E. Aubin, 1991. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J. Cell. BioI., 114: 373-384.
117. Ulloa-Montoya, F., C.M. Verfaillie and W.S. Hu, 2005. Culture systems for pluripotent stem cells. J. Biosci. Bioeng., 100: 12-27.
118. Vats, A, N.S. Tolley, J.M. Polak and J.E. Gough, 2003. Scaffolds and biomaterials for tissue engineering: A review of clinical applications. Clin. Otolaryngol. Allied Sci., 28: 165-172.
119. Vermeulen, A.H., C. Vermeer and F.T. Bosman, 1989. Histochemical detection of osteocalcin in normal and pathological human bone. J. Histochem. Cytochem., 37: 1503-1508.
120. Vukicevic, S., F.P. Luyten and AH. Reddi, 1989. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc. Natl. Acad. Sci. USA, 86: 8793-8797.
121. Yabe, T., A. Nemoto and T. Uemura, 1997. Recognition of osteopontin by rat bone marrow derived osteoblastic primary cells. Biosci. Biotechnol. Biochem., 61: 754-756.
122. Zhi, L.I. and L.I. Zu-Bing, 2005. Repair of mandible defect with tissue engineering bone in rabbits. ANZ J. Surg., 75: 1017-1021.